[1]张 辉,徐新保,何晓军,等.肝动脉栓塞化学治疗联合射频消融与再次手术切除治疗原发性肝癌术后复发的疗效比较[J].新乡医学院学报,2014,31(11):928-930.[doi:10.7683/xxyxyxb.2014.11.018]
点击复制

肝动脉栓塞化学治疗联合射频消融与再次手术切除治疗原发性肝癌术后复发的疗效比较
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
31
期数:
2014年11
页码:
928-930
栏目:
临床研究
出版日期:
2014-11-05

文章信息/Info

作者:
张 辉徐新保何晓军刘承利张洪义
中国人民解放军空军总医院肝胆外科,北京 100142
关键词:
原发性肝癌栓塞化学治疗射频消融再手术复发
DOI:
10.7683/xxyxyxb.2014.11.018
文献标志码:
A
摘要:
目的 比较肝动脉栓塞化学治疗联合射频消融(TACE +RFA)与再次手术切除治疗原发性肝癌切除术后复发的疗效。方法 回顾性分析中国人民解放军空军总医院确诊原发性肝癌行肝癌根治性切除术后、有肝内复发而无肝外转移的患者159例,其中行TACE +RFA治疗者(TACE +RFA组)87例,行再次手术切除治疗者(再手术组)72例,2组患者中均不包括肝功能Child C级患者。TACE +RFA组中最大肿瘤直径为4.5 cm,平均2.1 cm;再手术组中最大肿瘤直径为5.5 cm,平均3.5 cm。结果 TACE +RFA组患者均未出现严重并发症,而再手术组中1例死于术后肝衰竭,8例出现肝功能失代偿。TACE +RFA组和再手术组的1、2、3 a生存率分别为75.8%(66/87)、63.2%(55/87)、51.7%(45/87)和69.4%(50/72)、58.3%(42/72)、47.2%(34/72),差异均无统计学意义(P >0.05)。结论 对于原发性肝癌术后复发患者,TACE +RFA 与再次手术切除治疗相比,其疗效及预后相近,但TACE +RFA 适应证更宽,术后出现肝衰竭的概率低,术后肝功能损害恢复快。

相似文献/References:

[1]常旭,区庆嘉.干扰素α-2b对原发性肝癌切除及肝动脉栓塞术后T细胞亚群的影响 [J].新乡医学院学报,1995,12(04):337.
[2]冯献明,付方现,刘俊叶,等.艾迪注射液联合5-氟尿嘧啶加顺铂化疗方案治疗中晚期肝癌[J].新乡医学院学报,2010,27(03):273.
[3]王云检,张 珉,张 玲,等.原发性肝癌非根治性切除术中肝断面处理方法研究[J].新乡医学院学报,2019,36(8):732.[doi:10.7683/xxyxyxb.2019.08.007]
 WANG Yun-jian,ZHANG Min,ZHANG Ling,et al.Study on the treatment of residue liver in non-radical hepatectomy of primary liver cancer[J].Journal of Xinxiang Medical University,2019,36(11):732.[doi:10.7683/xxyxyxb.2019.08.007]
[4]李 靖,肖金成,郑 琳,等.肝动脉栓塞化学治疗与肝动脉栓塞治疗原发性肝癌疗效比较[J].新乡医学院学报,2018,35(11):981.[doi:10.7683/xxyxyxb.2018.11.008]
 LI Jing,XIAO Jing-cheng,ZHENG Lin,et al.Comparison of the effect of transcatheter arterial embolization and transcatheter arterial chemoem-bolization in treatment of primary liver cancer[J].Journal of Xinxiang Medical University,2018,35(11):981.[doi:10.7683/xxyxyxb.2018.11.008]
[5]王 瑛,袁鹤立,张 博,等.肠内营养对行肝动脉化学治疗栓塞术原发性肝癌患者血清炎性因子及免疫细胞的影响[J].新乡医学院学报,2019,36(11):1064.[doi:10.7683/xxyxyxb.2019.11.014]
 WANG Ying,YUAN He-li,ZHANG Bo,et al.Effect of enteral nutrition on the levels of serum inflammatory factors and immune cells in patients with primary hepatocellular carcinoma after transcatheter arterial chemoembolization[J].Journal of Xinxiang Medical University,2019,36(11):1064.[doi:10.7683/xxyxyxb.2019.11.014]
[6]陈文换,杨峰燕,张艳华,等.原发性肝癌组织中微RNA-543表达与微血管密度的相关性[J].新乡医学院学报,2021,38(7):662.[doi:10.7683/xxyxyxb.2021.07.013]
 CHEN Wenhuan,YANG Fengyan,ZHANG Yanhua,et al.Correlation between microRNA-543 expression and microvessel density in primary liver cancer tissues[J].Journal of Xinxiang Medical University,2021,38(11):662.[doi:10.7683/xxyxyxb.2021.07.013]
[7]周世凤,詹 玮,边成富.右美托咪定对行肝叶切除术原发性肝癌患者氧化应激、肝功能及外周血单核细胞内Toll样受体2和Toll样受体4表达的影响[J].新乡医学院学报,2020,37(9):869.[doi:10.7683/xxyxyxb.2020.09.015]
 ZHOU Shifeng,ZHAN Wei,BIAN Chengfu.Effect of dexmedetomidine on oxidative stress,liver function and expression of Toll-like receptor 2 and Toll-like receptor 4 in peripheral blood monouclear cells in patients with primary liver cancer undergoing hepalobectomy[J].Journal of Xinxiang Medical University,2020,37(11):869.[doi:10.7683/xxyxyxb.2020.09.015]
[8]梁长华,毛华杰,梁 盼,等.原发性肝癌320排容积CT灌注参数值与肿瘤体积及肝功能Child-Pugh分级的相关性[J].新乡医学院学报,2018,35(1):065.[doi:10.7683/xxyxyxb.2018.01.016]
 LIANG Chang-hua,MAO Hua-jie,LIANG Pan,et al.Correlation between 320 row volume CT perfusion parameters of primary liver cancer and liver tumor volume and liver function Child-Pugh classification[J].Journal of Xinxiang Medical University,2018,35(11):065.[doi:10.7683/xxyxyxb.2018.01.016]
[9]王 雷,王煜霞,薛会朝.多药耐药相关蛋白在原发性肝癌患者外周血淋巴细胞及癌组织中的表达[J].新乡医学院学报,2017,34(6):538.[doi:10.7683/xxyxyxb.2017.06.024]
 WANG Lei,WANG Yu-xia,XUE Hui-chao.Expression of multidrug resistance related proteins of P-glycoprotein,lung resistance protein and glutathione S-transferase-π in peripheral blood lymphocytes and cancer tissues in patients with hepatocellular carcinoma[J].Journal of Xinxiang Medical University,2017,34(11):538.[doi:10.7683/xxyxyxb.2017.06.024]
[10]任同良.微波消融与手术切除治疗原发性肝癌疗效比较[J].新乡医学院学报,2017,34(11):991.[doi:10.7683/xxyxyxb.2017.11.009]
 REN Tong-liang.Comparison of the effect of microwave ablation and surgical resection in the treatment of primary liver cancer[J].Journal of Xinxiang Medical University,2017,34(11):991.[doi:10.7683/xxyxyxb.2017.11.009]

更新日期/Last Update: 2014-11-14